The Transversus Abdominis Plane Block: A Prospective Randomized Clinical Trial Using EXPAREL.

Spectrum Health Hospitals

Status and phase: Completed; Phase 4

Conditions: Postoperative Pain

Treatments: Procedure: TAP Block; Drug: Exparel

Study type: Interventional

Funder types: Other

Identifiers

NCT02263963

DDI.FY13.07 (Other Identifier)

2013-066

Details and patient eligibility

About

The purpose of the study is to evaluate the effectiveness of EXPAREL in a transversus abdominis plane block by assessing the demand of postoperative narcotic, length of hospital stay and incidence of postoperative complications.

Enrollment: 50 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Patients over the age of 18 years w
2. Elective laparoscopic colorectal resection.

Exclusion criteria

1. Patients under 18 years.
2. Patients unable to provide informed consent
3. Patients undergoing emergency surgery.
4. Pregnant women
5. Severe liver or kidney disease (GFR 15-29 ml/min)

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

50 participants in 2 patient groups

TAP Block Experal

Experimental group

Description:

Patient who randomized to this arm, will be blinded, TAP block will be performed under ultrasound guidance, where 20-30 ml of Exparel will be injected in transversus abdominis plane, bilaterally.

Treatment:

Procedure: TAP Block

Drug: Exparel

No TAP Block

No Intervention group